These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24894748)

  • 21. Pharmacokinetic and pharmacodynamic interactions between metoprolol and dronedarone in extensive and poor CYP2D6 metabolizers healthy subjects.
    Damy T; Pousset F; Caplain H; Hulot JS; Lechat P
    Fundam Clin Pharmacol; 2004 Feb; 18(1):113-23. PubMed ID: 14748763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
    Zineh I; Beitelshees AL; Gaedigk A; Walker JR; Pauly DF; Eberst K; Leeder JS; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker users.
    Bijl MJ; Visser LE; van Schaik RH; Kors JA; Witteman JC; Hofman A; Vulto AG; van Gelder T; Stricker BH
    Clin Pharmacol Ther; 2009 Jan; 85(1):45-50. PubMed ID: 18784654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential cardiotoxic reaction involving rivastigmine and beta-blockers: a case report and review of the literature.
    Paulison B; Léos CL
    Cardiovasc Toxicol; 2010 Dec; 10(4):306-10. PubMed ID: 20865460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone and beta-adrenergic blockers: an interaction with metoprolol but not with atenolol.
    Leor J; Levartowsky D; Sharon C; Farfel Z
    Am Heart J; 1988 Jul; 116(1 Pt 1):206-7. PubMed ID: 3394625
    [No Abstract]   [Full Text] [Related]  

  • 26. CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction.
    Goryachkina K; Burbello A; Boldueva S; Babak S; Bergman U; Bertilsson L
    Eur J Clin Pharmacol; 2008 Dec; 64(12):1163-73. PubMed ID: 18648788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete atrioventricular block associated with concomitant use of metoprolol and paroxetine.
    Onalan O; Cumurcu BE; Bekar L
    Mayo Clin Proc; 2008 May; 83(5):595-9. PubMed ID: 18452693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CYP2D6 polymorphism and its impact on the clinical response to metoprolol: A systematic review and meta-analysis.
    Meloche M; Khazaka M; Kassem I; Barhdadi A; Dubé MP; de Denus S
    Br J Clin Pharmacol; 2020 Jun; 86(6):1015-1033. PubMed ID: 32090368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of amiodarone use on metoprolol concentrations, α-OH-metoprolol concentrations, metoprolol dosing and heart rate: A cross-sectional study.
    Robert S; Pilon MO; Oussaïd E; Meloche M; Leclair G; Jutras M; Gaulin MJ; Mongrain I; Busseuil D; Tardif JC; Dubé MP; de Denus S
    Pharmacol Res Perspect; 2023 Oct; 11(5):e01137. PubMed ID: 37732835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of CYP2D6 genotype on metoprolol plasma concentration and beta-adrenergic inhibition during long-term treatment: a comparison with bisoprolol.
    Nozawa T; Taguchi M; Tahara K; Hashimoto Y; Igarashi N; Nonomura M; Kato B; Igawa A; Inoue H
    J Cardiovasc Pharmacol; 2005 Nov; 46(5):713-20. PubMed ID: 16220080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study.
    Fux R; Mörike K; Pröhmer AM; Delabar U; Schwab M; Schaeffeler E; Lorenz G; Gleiter CH; Eichelbaum M; Kivistö KT
    Clin Pharmacol Ther; 2005 Oct; 78(4):378-87. PubMed ID: 16198657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of genotype-predicted CYP2D6 metabolism on clinical effects and tolerability of metoprolol in patients after myocardial infarction - a prospective observational study.
    Anstensrud AK; Molden E; Haug HJ; Qazi R; Muriq H; Fosshaug LE; Spigset O; Øie E
    Eur J Clin Pharmacol; 2020 May; 76(5):673-683. PubMed ID: 31940084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the CYP2D6 genotype on the clinical effects of metoprolol: a prospective longitudinal study.
    Rau T; Wuttke H; Michels LM; Werner U; Bergmann K; Kreft M; Fromm MF; Eschenhagen T
    Clin Pharmacol Ther; 2009 Mar; 85(3):269-72. PubMed ID: 19037197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining Antidepressants with β-Blockers: Evidence of a Clinically Significant CYP2D6 Drug Interaction.
    Shin J; Hills NK; Finley PR
    Pharmacotherapy; 2020 Jun; 40(6):507-516. PubMed ID: 32342526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Syncope and sinus bradycardia from combined use of thalidomide and beta-blocker.
    Yamaguchi T
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):1033-5. PubMed ID: 18613249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol.
    Saarikoski T; Saari TI; Hagelberg NM; Backman JT; Neuvonen PJ; Scheinin M; Olkkola KT; Laine K
    Eur J Clin Pharmacol; 2015 Mar; 71(3):321-7. PubMed ID: 25560051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of metoprolol pharmacokinetics and hemodynamics by diphenhydramine coadministration during exercise testing in healthy premenopausal women.
    Sharma A; Pibarot P; Pilote S; Dumesnil JG; Arsenault M; Bélanger PM; Meibohm B; Hamelin BA
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1172-81. PubMed ID: 15718288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metoprolol in hypertension: an open evaluation.
    Assaykeen TA; Michell G
    Med J Aust; 1982 Jan; 1(2):73-7. PubMed ID: 7040924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical timolol for treatment of epistaxis in hereditary haemorrhagic telangiectasia associated with bradycardia: a look at CYP2D6 metabolising variants.
    Epperla N; Brilliant MH; Vidaillet H
    BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24518395
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.